Drug Approval | July 26, 2023
Eugia Pharma receives USFDA approval for Plerixafor Injection
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
The CHMP’s recommendation will now be reviewed by the European Commission for marketing authorization in the European Union
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
This transformation will enable GE HealthCare to build a strong foundation for business growth
Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications
The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Subscribe To Our Newsletter & Stay Updated
